Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,400
+220 (1.97%)
At close: Apr 2, 2026

KRX:007570 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
23,6544,2953,4147,1749,288
Short-Term Investments
5,9738,49510,2765,41934,111
Trading Asset Securities
----231.78
Cash & Short-Term Investments
29,62712,79013,69012,59343,631
Cash Growth
131.64%-6.57%8.72%-71.14%4.85%
Accounts Receivable
44,97244,77747,65648,76252,803
Other Receivables
3,9403,9364,6804,7163,297
Receivables
48,91248,71352,33653,47956,101
Inventory
64,24359,87353,10848,38732,423
Prepaid Expenses
651.12158.02186.42303.23515.3
Other Current Assets
4,3293,6524,3393,6563,671
Total Current Assets
147,762125,187123,659118,418136,340
Property, Plant & Equipment
220,675216,421181,973178,244175,779
Long-Term Investments
40,67843,51038,57252,84745,029
Other Intangible Assets
1,7121,8881,8261,9352,078
Long-Term Deferred Charges
24,03923,45325,53029,48134,392
Other Long-Term Assets
22,46420,56821,04621,99125,643
Total Assets
457,331431,027392,607402,916419,261
Accounts Payable
20,70422,32226,30729,81323,717
Accrued Expenses
480.55513.8398.44310.58314.19
Short-Term Debt
96,21692,50565,78971,00092,500
Current Portion of Long-Term Debt
3,333--2,000-
Current Portion of Leases
189.5266.59522.11370.52159.24
Current Income Taxes Payable
236.41,2931,126958.543,542
Other Current Liabilities
50,01240,64945,12140,87547,687
Total Current Liabilities
171,172157,549139,263145,328167,920
Long-Term Debt
26,66714,7006,000-5,000
Long-Term Leases
388.51209.38339.24732.69843.73
Pension & Post-Retirement Benefits
7,0188,5807,3227,9098,136
Long-Term Deferred Tax Liabilities
8,2278,5659,23310,66210,464
Other Long-Term Liabilities
2,4501,8915050021.5
Total Liabilities
215,922191,494162,207165,132192,385
Common Stock
47,71447,71447,71447,71447,714
Additional Paid-In Capital
78,37078,37078,44178,41678,590
Retained Earnings
122,790118,75953,55958,75943,170
Treasury Stock
-12,269-11,269-11,921-10,075-7,437
Comprehensive Income & Other
-114.371,26457,95758,49660,587
Total Common Equity
236,490234,838225,751233,311222,624
Minority Interest
3,8053,5823,5363,3613,139
Shareholders' Equity
241,409239,533230,400237,785226,876
Total Liabilities & Equity
457,331431,027392,607402,916419,261
Total Debt
126,794107,68172,65074,10398,503
Net Cash (Debt)
-97,168-94,891-58,960-61,511-54,872
Net Cash Per Share
-5277.21-5148.09-3272.13-3393.60-3014.10
Filing Date Shares Outstanding
19.7918.0117.9718.0918.21
Total Common Shares Outstanding
19.7918.0117.9718.0918.21
Working Capital
-23,410-32,362-15,604-26,910-31,580
Book Value Per Share
11951.5613036.8712561.4212899.4512228.63
Tangible Book Value
234,778232,951223,925231,375220,547
Tangible Book Value Per Share
11865.0512932.0712459.7912792.4612114.49
Land
118,556120,507120,298120,308116,955
Buildings
39,55841,12642,78744,47445,995
Machinery
2,9944,0556,0609,3679,480
Construction In Progress
58,41549,58311,4352,3841,953
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.